E-cadherin immimohistochemical expression in mammary gland neoplasms in bitches

Polish Journal of Veterinary Sciences

Volumn 11, Issue 1, 2008, Pages 47-54

  Rodo, A ^a   Malicka, E ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Dogs; E cadherin; Mammary gland; Neoplasms

Indexed keywords

CANIDAE; CANIS FAMILIARIS;

CADHERIN;

ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CARCINOMA; DOG; DOG DISEASE; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ADENOMA; ANIMALS; CADHERINS; CARCINOMA; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL;

EID: 41349114859     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Asgeirsson KS, Jonassom JG, Tryggvadottir L, Olafsdottir K, Sigurgeirsdottir JR, Ingvarsson S, Ogmundstottir HM (2000) Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance. Eur J Cancer 36: 1098-1106.
2. Benjamin SA, Lee AC, Saunders WJ (1999) Classification and behaviour of canine mammary epithelial neoplasms based on life-span observation in beagles. Vet Pathol 36: 423-436.
3. Brunetti B, Sarli G, Preziosi I, Monari I, Benazzi C (2005) E-cadherin and β-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors. Vet Pathol 42: 781-787.
4. Brunetti B, Sarli G, Preziosi R, Leprotti S, Benazzi C (2003) E-cadherin expression in canine mammary carcinoma with regional lymph node metastases. J Vet Med 50: 496-500.
5. Charbin C, Bonnier P, Garcia S, Andrac L, Crebassa B, Dorel M, Lavaut MN, Allasia C (1999) E-cadherin and β-catenin expression in breast medullary carcinomas. Int J Oncol 15: 285-292.
6. Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17: 499-508.
7. St. Croix B, Sheehan C, Rak JW, Flrrenes VA, Slingerland JM, Kerbel RS (1998) E-cadherin- dependent growth suppression is mediated by the cyclin- dependent kinase inhibitor p27 KIP1. J Cell Biol 142: 557-571.
8. McEntee MF, Brenneman KA (1999) Dysregulation of β-catenin is common in canine sporadic colorectal tumors. Vet Pathol 36: 228-236.
9. Fricke E, Keller G, Becker I, Rosinatz E, Schott C, Plaschke S, Rudelius M, Hermannstadter C, Busch R, Hofler H, Becker KF, Luber B (2003) Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma. Int J Cancer 104: 60-65.
10. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lohner D, Birchmeier W (1991) E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185.
11. Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N, Doi K (2000) Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol 37: 177-183.
12. Gilbertson S, Kurzman I, Zachrau R, Hurritz A, Black M (1983) Canine mammary epithelial neoplasms: biologic implication of morphologic characteristics assessed in 232 dogs. Vet Pathol 20: 127-142.
13. Goldstein NS, Kestin LL, Vicini FA (2001) Clinicopathologic implications of E cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 92: 738-747.
14. Lee JL, Chang CJ, Wu SY, Sargan DR, Lin CT (2004) Secreted frizzled- related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal glands. Breast Cancer Res Treat 84: 139-149.
15. Löhr CV, Teifke JP, Failing K, Weiss E (1997) Characterization the standarized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 34: 212-221.
16. Malicka E, Piusiński W, Sendecka H, Bielecki W, Osińska B, Lenartowicz-Kubrat Z (1996) Nowotwory psów stwierdzane w badaniach anatomopatologicznych w latach 1985-1993. Med Weter 2: 103-106.
17. Misdorp W (2002) Tumors of the mammary gland. In: Meuten DJ (ed) Tumors in domestic animals. Iowa State Press, pp 575-606.
18. Misdorp W, Else RW, Hellmen E, Lipscomb T.P (1999) Histological classification of mammary tumors of the dog and cat, Bulletin of the World Health Organization, Geneva.
19. Menon MM, Simha MM (1998) Cell adhesion molecule E-cadherin and cellular proliferation marker AgNOR in bladder lesions- usefulness and limitations. Int J Cancer 35: 142-146.
20. Moulton JE (1990) Tumors of the mammary gland. In: Moulton JE (ed) Tumors in domestic animals, University of California Press, pp 518-552.
21. Mulas JM, Millhn Y, Dios R (2005) A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease- free period in mammary tumors of the dog. Vet Pathol 42: 200-212.
22. Nieto A, Pěna L, Pérez- Alenza MD, Sánchez MA, Flores JM, Castaño M (2000) Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 37: 239-247.
23. Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ (2003) Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 17: 102-106.
24. Pena LL, Nieto AI, Perez-Alenza D (1998) Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: Relationship to clinical and pathologic variables. J Vet Diagn Invest 10: 237-246.
25. Reis AL, Carvalheira J, Schmitt FC, Gartner F (2003) Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Vet Rec 152: 621-624.
26. Reis- Filho (2002) Clinicopathologic implications of E-cadherin reactivity with lobular carcinoma in situ of the breast. Cancer 94: 2114-2115.
27. Rodo A (2007) Ekspresja receptora HER-2, kadheryny E oraz białka p53 w nowotworach gruczołu sutkowego suk. Doctoral thesis. SGGW, Warszawa.
28. Sarli G, Preziosi R, De Tolla L, Brunetti B, Benazzi C (2004) E-cadherin immunoreactivity in canine mammary tissues. J Vet Diagn Invest 16: 542-547.
29. Szczubiał M, Łopuszyński W (2002) Rokowanie w nowotworach gruczołu mlekowego suk. Med Weter 58: 261-264.
30. Torres LN, Matera JM, Vasconcellos CH, Avanzo JL, Hernandez-Blazquez EJ, Daglo ML (2005) Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Vet Pathol 42: 633-641.